Why are atherogenic the apoB lipoproteins: The response to retention hypothesis;Por qué son aterogénicas las lipoproteínas apoB del plasma: La hipótesis de respuesta a la retención

Investigacion Clinica

Volumn 42, Issue SUPPL. 1, 2001, Pages 43-73

  Hurt Camejo, E ^a   Camejo, G ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

ApoB; Atheroesclerosis; Extracellular matrix; Inflammation; Proteoglycans

Indexed keywords

APOLIPOPROTEIN B; CYTOKINE; GLYCOSAMINOGLYCAN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; HYDROLYSIS; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; LIPID ANALYSIS; MACROPHAGE; OXIDATION; SMOOTH MUSCLE FIBER;

APOLIPOPROTEINS B; ARTERIOSCLEROSIS; EXTRACELLULAR MATRIX; HUMANS; OXIDATION-REDUCTION; TUNICA INTIMA;

EID: 0034989489     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (100)

1. Cholesterol reduction yields clinical benefit: Impact of statin trials
2. Mechanical stress mechanism and the cell. An endothelial paradigm
3. The role of endothelium in atherogenesis
4. Novel inflammatory markers of coronary risk: Theory versus practice
5. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
6. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentrations precede development of fatty streak lesions
7. Selective increase in cholesterol at atherosclerosis-susceptible aortic sites after short-term cholesterol feeding
8. Initiation of atherosclerotic lesions in cholesterol fed rabbits. II Selective retention of LDL versus selective increases in LDL permeability in susceptible sites of arteries
9. Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerosis compared with non-lesioned rabbit aorta
10. Serum lipoproteins of amazonian indians and inhabitants of an urban area of Venezuela fractionated by preparative ultracentrifugation
11. The diet and 15 year-death rate in the Seven Countries Study
12. Major risk factors and primary prevention: Overview
13. Relationship between low density lipoprotein in aortic intima and serum lipid levels
14. Lipids and low density lipoproteins in intima in relation to its morphological characteristics. Athero genesis Initiating Factors
15. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
16. Lipoproteins, lipoprotein oxidation and atherogenesis
17. The response-to-retention hypothesis of early atherogenesis
18. The response-to-retention hypothesis of atherogenesis reinforced
19. Cellular consequences of the association of apoB lipoproteins with proteoglycans: Potential contribution to atherogenesis
20. Association of lipoproteins with arterial proteoglycans: Pathological significance
21. Atherosclerosis: An inflammatory disease
22. Development of the lipid-rich core in human atherosclerosis
23. Selective retention of VLDL, IDL and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo
24. Prelesional events in atherogenesis
25. Distribution of plasma proteins across the human aortic wall: Barrier functions and endothelium and internal elastic lamina
26. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system
27. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits
28. Properties of lipoprotein complexes isolated by affinity chromatography from human aorta
29. Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries
30. The human aorta: Sulfate-containing polyuronides and the deposition of cholesterol
31. Glycosaminoglycans: Molecular properties, protein interactions and role in physiological processes
32. The Vascular Extracellular Matrix
33. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein: A deep-etch and Immunolocalization study of ultrarapidly frozen tissue
34. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit
35. A definition of the intima of human arteries and its atherosclerosis-prone regions
36. Identification of apoB-100 segments mediating the interaction of low density lipoproteins hpoproteins with arterial proteoglycans
37. Proteoglycans and lipoproteins in atherosclerosis
38. Molecular parameters that control the association of low density lipoprotein apoB-100 with chondroitin sulphate
39. Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: Effects of the lipid environment
40. Lipoprotein mucopolysaccharides complexes from human atherosclerotic lesions
41. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages
42. The structural stability of low density lipoprotein: A kinetic x-ray scattering study of its interaction with arterial wall proteoglycans
43. Modifications of low density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate
44. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
45. The oxidation of lipoproteins by monocyte macrophages
46. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
47. Human phagoeytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosisne and isodityrosine by a tyrosyl radical-dependent pathway
48. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
49. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans
50. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells
51. Vascular shear forces and atherogenesis: Role of shear-provoked endothelial viral infection and heme iron accumulation
52. Hemin binding and oxidation of lipoproteins in serum: Mechanisms and effect on the interaction of LDL with human macrophages
53. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
54. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insuficiency
55. Development of the lipid-rich core in human atherosclerosis
56. Lipoprotein receptors and cellular cholesterol metabolism in health and disease
57. Potential involvement of type II phospholipase A2 in atherosclerosis
58. Macrophages stimulate cholesteryl ester accumulation in cocultured smooth muscle cells incubated with lipoprotein proteoglycan complex
59. Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages
60. Interaction of LDL with human arterial proteoglycans stimulates its uptake by humam monocyte-derived macrophages
61. Differential expression of scavenger receptor isoforms during monocytemacrophage diffrentiation and foam cell formation
62. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apolipoprotein(a)
63. Cell-mediated immunity in atherosclerosis
64. The Yin and Yang of oxidation in thre development of the fatty streak
65. The L-argininenitric oxide pathway: Role in atherosclerosis and therapeutic implications
66. Interferon gamma binds to extracellular matrixchondroitin-sulfate proteoglycans, thus enhancing its cellular response
67. Phospholipase A2 enzymes: Regulation and inhibition
68. Localization of non pancreatic secretory phospholipase A2 in normal and atherosclerotic arteries: Activity of the isolated enzyme on low density lipoproteins
69. Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human aorta
70. Inhibition of human secretory class II phospholipase A2 by heparin
71. Binding of human phospholipase A2 type II to proteoglycans: Differential effect of glycosaminoglycans on enzyme activity
72. Molecular basis for the association of group IIA phospholipase A2 and decorin in human atherosclerotic lesions
73. Secretory group II phospholipase A2: A newly recognized acute-phase reactant with a role in atherogenesis
74. Impaired endotheliummediated relaxation to aggregating plateletes and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis
75. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta
76. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
77. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells
78. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cell
79. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages
80. Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype
81. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease
82. Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism
83. Variations in oxidation susceptibility among six low density lipoprotein subfractions of different density and particle size
84. Interaction of LDL with an arterial proteoglycan: Correlation with ischemic heart disease and lipoprotein structure
85. The interaction of low density lipoproteins with arterial proteoglycans: An additional risk factor?
86. The affinity of low density lipoproteins for an arterial macromolecular complex: A study in ischemic heart disease and controls
87. Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction
88. Interaction of very-low-density, and low density lipoproteins with human arterial proteoglycans
89. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor
90. Phospholipase A2 modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans
91. Circulating levels of secretory phospholipase A2 predict coronary events in patients with coronary artery disease
92. The prognosis value of C-reactive protein and serum amyloid A protein in severe unstable angina
93. Inflammation, Aspirin, and their risk of cardiovascular disease in apparently healthy men
94. Traffic signals on endotheliumfor leukocytes in health, inflammation, and atherosclerosis
95. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation
96. The unstable atheroma
97. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
98. Lipid lowering reduces matrix-degrading proteinases activity in atheroma of hypercholesterolemic rabbits: A new mechanism of lesion stabilization
99. MCP-1 expression in a rabbit model of atherosclerosis Role of nuclear factor kB, reduces neointimal formation, Atorvastatin abolishes macrophages infiltration
100. Hypercholesterolemia causes mechanical weakening of rabbit atheroma: Local collagen loss a prerequisite of plaque rupture